Search / 465 results found

  • Updated

Public health officials warn that moves by rich countries to buy large quantities of monkeypox vaccine could leave millions of people in Africa unprotected against a more dangerous version of the disease. Scientists say that  and risk continued spillovers of the virus into humans unlike the campaigns to stop COVID-19, mass vaccination won’t be necessary to curb monkeypox outbreaks. They think targeted vaccination, along with other measures, could be enough to shut down the multiple outbreaks. Monkeypox is much harder to spread than the coronavirus. But experts warn that if the disease spills over into general populations, the need for vaccines could intensify, especially if it becomes entrenched in new regions.

  • Updated

The U.S. economy is caught in an awkward, painful place. A confusing one, too. Growth appears to be sputtering, home sales are tumbling and economists warn of a potential recession ahead. But consumers keep spending, businesses keep posting profits and the economy keeps adding hundreds of thousands of jobs each month. In the midst of it all, prices have accelerated to four-decade highs, and the Federal Reserve is desperately trying to douse the inflationary flames with higher interest rates. That’s making borrowing more expensive for households and businesses. The Fed hopes to pull off the triple axel of central banking: Slow the economy just enough to curb inflation without causing a recession.